The World Journal of Men's Health (Apr 2017)

Clinicopathologic Characteristics and Treatment Outcomes of Penile Cancer

  • Jong Kil Nam,
  • Dong Hoon Lee,
  • Sung Woo Park,
  • Sung Chul Kam,
  • Ki Soo Lee,
  • Tae Hyo Kim,
  • Taek Sang Kim,
  • Cheol Kyu Oh,
  • Hyun Jun Park,
  • Tae Nam Kim

DOI
https://doi.org/10.5534/wjmh.2017.35.1.28
Journal volume & issue
Vol. 35, no. 1
pp. 28 – 33

Abstract

Read online

Purpose: The aim of this study was to assess the clinicopathologic characteristics of penile cancer, including patterns of therapy, oncologic results, and survival. Materials and Methods: Between January 2005 and July 2015, 71 patients at 6 institutions who had undergone penectomy or penile biopsy were enrolled. Their medical records were reviewed to identify the mode of therapy, pathology reports, and cancer-specific survival (CSS) rate. Results: Clinicopathologic and outcome information was available for 52 male patients (mean age, 64.3 years; mean follow-up, 61.4 months). At presentation, 17 patients were node-positive, and 4 had metastatic disease. Management was partial penectomy in 34 patients, total penectomy in 12 patients, and chemotherapy or radiotherapy in 6 patients. The pathology reports were squamous cell carcinoma in 50 patients and other types of carcinoma in the remaining 2 patients. Kaplan-Meier survival analysis showed a 5-year CSS rate of 84.0%. In univariate and multivariate analyses, the American Joint Committee on Cancer (AJCC) stage and pathologic grade were associated with survival. Conclusions: Partial penectomy was the most common treatment of penile lesions. The oncologic outcomes were good, with a 5-year CSS of 84.0%. The AJCC stage and pathologic grade were independent prognostic factors for survival.

Keywords